Kenei Pharmaceutical

What Kenei Pharmaceutical does

Kenei Pharmaceutical Co., Ltd. (健栄製薬株式会社) is a privately-held Japanese pharmaceutical manufacturer founded in 1946 and headquartered in Osaka, with a workforce of 501-1000 employees. The company specializes in the manufacture and sale of disinfectants, pharmacopoeia-grade (局方品) pharmaceuticals, and over-the-counter (OTC) health products, positioning itself as the self-described No. 1 manufacturer of disinfectants and pharmacopoeia products in Japan.

The product portfolio centers on two technology pillars. The first is alcohol-based disinfection, led by the 手ピカジェル (Tepika) consumer series — a pH-adjusted gel with 76.9-81.4 vol% ethanol and added phosphoric acid for enhanced bactericidal action — and medical-grade equivalents (ラビショット/ラビジェル, ジアンフォーム, ザルクリーン, フタラール 0.55%). The second is dermatological and gastrointestinal care, including ヒルマイルド (Healmild) topical heparinoid 0.3% lotions and creams, 酸化マグネシウムE便秘薬 magnesium-oxide laxatives, ベビーワセリン petroleum jelly, and 健栄うがい薬/明治うがい薬 oral care products. Specialty items include ハッカ油 (mint oil) and ノロパンチ (norovirus disinfectant). Formulation expertise and pharmacopoeia compliance underpin the product line.

The business model operates three revenue streams: (1) OTC consumer products sold through nationwide pharmacy and drug store retail plus a small owned e-commerce storefront (kenei-online.shop); (2) prescription pharmaceuticals and medical-grade disinfectants sold to hospitals and clinics via a dedicated MR (Medical Representative) field sales force and a 学術情報部 (academic information division); and (3) OEM/contract manufacturing services to other pharmaceutical companies, including manufacturing and marketing approval transfers (e.g., the 2022 succession of 明治うがい薬 from Meiji Seika Pharma). The go-to-market is sales-led, with content marketing (Kenei Life blog, dedicated brand sites, social media) supporting the consumer side and academic content (Kenei Disinfectant Handbook, hospital infection control manuals) supporting the medical-professional channel. Pricing is not publicly disclosed and is handled through MR negotiations for institutional accounts and standard retail for OTC.

Name

Kenei Pharmaceutical

Legal name

健栄製薬株式会社 (Kenei Pharmaceutical Co., Ltd.)

Website

https://kenei-pharm.com

Company type

Private

Founded year

1946

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Kenei Pharmaceutical (健栄製薬株式会社) is a privately-held Japanese pharmaceutical manufacturer founded in 1946, headquartered in Osaka, specializing in disinfectants, pharmacopoeia-grade pharmaceuticals, and OTC health products sold to healthcare institutions via an MR network and to general consumers through pharmacy retail and owned e-commerce.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industries

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB)

Keywords

• Pharmaceutical manufacturing
• Disinfectant products
• Hand sanitizers
• Medical supplies
• OTC medications

Headquarters

HQ city

Osaka

HQ country

Japan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. OTC Pharmaceutical Products: Sale of over-the-counter pharmaceutical products to general consumers through pharmacies, drug stores, and the company's owned e-commerce platform (kenei-online.shop). Product lines include hand sanitizers (手ピカジェル series), constipation medications (酸化マグネシウムE便秘薬), topical moisturizers (ヒルマイルド), vaseline-based products (ベビーワセリン), gargle solutions (健栄うがい薬/明治うがい薬), and menthol oil (ハッカ油).
2. Medical/Prescription Pharmaceutical Products: Sale of prescription pharmaceuticals to healthcare institutions, hospitals, and clinics. Product lines include 酸化マグネスウム錠「ケンエー」 (Magnesium Oxide Tablets Kenei), 白色ワセリン「ケンエー」 (White Vaseline Kenei), ラビショット・ラビジェル (hand sanitizers for medical use), ジアエンフォーム, ザルクリーン, and フタラール消毒液0.55％「ケンエー」.
3. OEM/Contract Manufacturing: Provision of contract manufacturing and OEM/ODM services for pharmaceutical products, accepting manufacturing work from other pharmaceutical companies. The company also acquired the manufacturing and marketing approval for 明治うがい薬 (Meiji Gargle Medicine) in November 2022.
4. Medical Professional Educational Resources: Provision of educational materials, infection control guides, and academic information to medical professionals, distributed via dedicated healthcare portal and through MR (Medical Representative) network.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Kenei Pharmaceutical manufactures and sells over-the-counter (OTC) and medical-use pharmaceutical products, with a core specialization in alcohol-based disinfectants and hand sanitizers (Tepika series), topical dermatological treatments (Healmild heparinoid line), magnesium oxide laxatives, white vaseline, and medical-grade disinfectants. The company also provides OEM/contract manufacturing services to other pharmaceutical companies. Its products are sold in Japan through pharmacies, drug stores, a dedicated medical representative network, and an owned e-commerce storefront.

Product overview

Kenei Pharmaceutical is a Japanese pharmaceutical company specializing in OTC and medical-use disinfectants, sanitizers, and pharmaceutical products. The product portfolio centers on two main pillars: (1) Alcohol-based hand disinfectants and sanitizers led by the 手ピカ젤 (Tepika) series, and (2) Topical dermatological products led by the ヒルマイルド (Heal Mild) heparinoid creams/lotions, alongside internal digestive treatments (酸化マグネシウムE便秘薬, 酸化マグネシウム錠), petroleum jelly products (ベビーワセリン), and oral care (健栄のカバくん series including 明治うがい薬). For medical professionals, the company offers prescription-grade disinfectants including ラビショット・ラビジェル, ジアエンフォーム, ザルクリーン, and フタラール消毒液. The company positions itself as a specialist in infection control, with a focus on alcohol-based hand hygiene products and disinfectants as its core competency since founding in 1946.

Differentiator

Problem solved

Functional benefit

Brands

• 手ピカengel (Tepika): Hand sanitizer and hand disinfection products, including 手ピカengel プラス (Tepika Gel Plus) and 手ピカengel スペシャル (Tepika Special)
• ヒルマイルド (Healmild)
• 酸化マグネシウムE便秘薬 (Magnesium Oxide E Constipation Medicine)
• ベビーワセリン (Baby Vaseline)
• 健栄のカバくんシリーズ (Kenei Kabakun Series)
• ハッカ油 (Mint Oil)

Products and services

• Tepika Gel Series (手ピカジェル)
• Healmild Series (ヒルマイルド)
• Magnesium Oxide E Laxative (酸化マグネシウムE便秘薬)
• Baby Vaseline Series (ベビーワセリン)
• Kenei Kabakun Series (健栄のカバくんシリーズ) including Meiji Gargle Medicine (明治うがい薬)
• Mint Oil (ハッカ油)
• Noro Punch (ノロパンチ)
• Labi Shot / Labi Gel (ラビショット・ラビジェル)
• Ziaen Form (ジアエンフォーム)
• Zal Clean (ザルクリーン)
• Phtharal Disinfectant 0.55% Kenei (フタラール消毒液0.55%「ケンエー」)
• Magnesium Oxide Tablets Kenei (酸化マグネシウム錠「ケンエー」)
• White Vaseline Kenei (白色ワセリン「ケンエー」)
• OEM/ODM Contract Manufacturing Service (受託製造・OEM供給)

Quantifiable outcome

• Ethanol concentration 76.9–81.4 vol% in 手ピアゼル Plus for effective broad-spectrum disinfection
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered major and core.

• 明治うがい薬 (Meiji Gargle Medicine)majorStrategic or Co-development Partner · 2 November 2022Kenei Pharmaceutical assumed the manufacturing and marketing approval (製造販売承認の了承) for the 明治うがい薬 (Meiji Gargle Medicine) product from Meiji Seika Pharma in November 2022, expanding Kenei's OTC product portfolio and distribution capabilities in the gargle medicine category.
• 三菱重工業株式会社 (Mitsubishi Heavy Industries)majorStrategic or Co-development Partner · 16 December 2021Kenei Pharmaceutical purchased the former Mitsubishi Heavy Industries 松阪工場 (Matsusaka Factory) site in December 2021 as part of the company's new factory construction initiative to expand manufacturing capacity. This strategic real estate acquisition enables Kenei's manufacturing scale-up.
• 大久保憲 (Okubo Ken)coreOthersDr. Ken Okubo serves as the supervisor/reviewer (監修) for the hand hygiene (手指衛生) section of Kenei Pharmaceutical's infection control academic information platform. He is Director of Hiraiwa Hospital, Medical Corporation Kojukai / Professor Emeritus, Tokyo Healthcare University.
• 尾家重治 (Oie Shigeharu)coreOthersProfessor Shigeharu Oie of Sanyo Onoda Tokyo University of Science, Faculty of Pharmacy, serves as the editor/author (編著) of Kenei Pharmaceutical's infection control academic information platform, specifically the '消毒薬の選び方' (How to Choose Disinfectants) section covering topics from basic disinfectant science to selection guidance for various microorganisms.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Rohto Pharmaceutical: Major Japanese OTC and personal care pharmaceutical company known for eye care (V Rohto) and topical products. Comparable as a Japanese manufacturer selling OTC consumer health products through pharmacy and consumer channels.
• Daiichi Sankyo Healthcare: OTC arm of Daiichi Sankyo producing consumer health products (Loxonin S, etc.). Comparable as a Japanese OTC pharmaceutical manufacturer operating in overlapping therapeutic categories.
• Kobayashi Pharmaceutical: Leading Japanese OTC household medicine and personal care manufacturer (e.g., Sawaday, Bluelet). Direct comparable in OTC consumer pharmaceutical manufacturing with strong brand portfolios sold through Japanese pharmacy channels.
• Maruishi Pharmaceutical: Japanese pharmaceutical company specializing in medical disinfectants and hygiene products. Highly comparable niche overlap in disinfectant manufacturing for healthcare institutions.
• Earth Corporation: Japanese household products manufacturer with significant pharmaceutical/OTC portfolio (insect repellents, hygiene products). Comparable in Japanese OTC consumer health with parallel pharmacy distribution.
• Taisho Pharmaceutical: One of Japan's largest OTC pharmaceutical companies with strong consumer brands (Lipovitan, Pabron). Directly comparable as a Japanese OTC pharma manufacturer serving both consumer and healthcare channels with overlapping product categories (dermatology, OTC medications).
• Sato Pharmaceutical: Japanese pharmaceutical manufacturer focused on OTC and prescription products, including dermatology (Mentholatum). Comparable mid-cap Japanese pharma with both OTC consumer and medical institution channels.
• Saraya: Japanese company specializing in hygiene, sanitation, and infection control products (hand soaps, sanitizers). Directly comparable as a Japan-based disinfectant and hand hygiene manufacturer with overlapping institutional and consumer channels.

Broad incumbents

• GOJO Industries (Purell): Global leader in hand hygiene (Purell brand) serving healthcare and consumer markets. Comparable as a broad incumbent in alcohol-based hand sanitization with similar institutional and consumer GTM motions.

Others

• Meiji Seika Pharma: Major Japanese pharmaceutical company that transferred the Meiji Gargle Medicine manufacturing approval to Kenei in November 2022. Relevant as a counterparty and large Japanese pharma that divested an OTC asset to Kenei, signaling Kenei's OEM positioning.

Market position

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/kenei_pharm
• Instagraminstagram.com/kenei_official_jp

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kenei Pharmaceutical